Who owns NOVOCURE LIMITED?

Tip: Access positions for across all investors

Analyze quarterly positions in Novocure with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Novocure stock

Who bought or sold NOVOCURE LIMITED this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Braidwell 136M $118M 0% Dec 2023
 View chart
Tenor Capital Management 91M $80B 7% Dec 2023
 View chart
Opti Capital Management 71M $62M 296% Sep 2023
 View chart
DeepCurrents Investment Group 45M $39M 0% Dec 2023
 View chart
Linden Advisors 42M $36B 14% Sep 2023
 View chart
Steelhead Partners 36M $31B -13% Dec 2023
 View chart
Balyasny Asset Management 25M $22M 0% Dec 2023
 View chart
State Street Corporation 15M $13M 25% Sep 2023
 View chart
Point72 Asset Management 8.0M $7.0M 100% Dec 2023
 View chart
Capstone Investment Advisors 5.3M $4.6M -28% Dec 2023
 View chart
Shenkman Capital Management 4.2M $3.6B -41% Dec 2023
 View chart
Jpmorgan Chase & Co 4.1M $3.6M 77% Dec 2023
 View chart
Kohlberg Kravis Roberts & Co 3.0M $2.6M 0% Dec 2023
 View chart
Bnp Paribas Investment Partners 3.0M $2.6M 0% Dec 2023
 View chart
Wells Fargo & Company 3.0M $2.6M 5% Dec 2023
 View chart
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 1.0M $866k 0% Dec 2023
 View chart
Palisade Capital Management 996k $865k 0% Dec 2023
 View chart
Zazove Associates 158k $138k 100% Dec 2023
 View chart
Leucadia National Corporation 118k $102k 973% Sep 2023
 View chart
Lake Street Advisors Group 29k $25k 7% Sep 2023
 View chart
Barclays 20k $17k 100% Dec 2023
 View chart
Verition Fund Management 18k $16M -10% Sep 2023
 View chart

Who sold out of Novocure?

Fund or Company Name Date Sold Shares Held Valued At
Oaktree Capital Management Jun 2023 1.6M $1.4M
Bank of New York Mellon Sep 2023 500k $429k
Jane Street Sep 2023 200k $172k